| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.951 | 16.514 | 12.600 | 8.891 | 8.851 | 2.359 | 7.803 | 10.889 | 9.979 | 13.429 |
| Total Income - EUR | 12.408 | 16.518 | 12.600 | 8.891 | 8.851 | 2.359 | 7.810 | 10.889 | 9.979 | 13.432 |
| Total Expenses - EUR | 8.775 | 5.277 | 5.900 | 8.955 | 5.486 | 1.743 | 5.101 | 7.161 | 8.563 | 9.348 |
| Gross Profit/Loss - EUR | 3.632 | 11.241 | 6.700 | -64 | 3.365 | 616 | 2.709 | 3.728 | 1.416 | 4.084 |
| Net Profit/Loss - EUR | 3.260 | 10.746 | 6.322 | -329 | 3.099 | 539 | 2.671 | 3.450 | 1.130 | 3.414 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Uromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.009 | 1.867 | 1.489 | 551 | 1.105 | 588 | 453 | 0 | 573 | 1.296 |
| Current Assets | 4.303 | 10.951 | 7.526 | 3.083 | 5.588 | 6.455 | 9.142 | 13.052 | 13.572 | 16.561 |
| Inventories | 41 | 41 | 841 | 1.034 | 1.836 | 1.801 | 1.768 | 0 | 584 | 581 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4.262 | 10.910 | 6.685 | 2.049 | 3.752 | 4.653 | 7.374 | 13.052 | 12.988 | 15.980 |
| Shareholders Funds | 5.191 | 12.657 | 8.804 | 3.585 | 6.615 | 7.028 | 9.550 | 13.024 | 14.114 | 17.449 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 121 | 161 | 211 | 48 | 77 | 14 | 45 | 29 | 32 | 408 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uromed Srl